Yangonin is primarily studied for its potential therapeutic effects, particularly in the context of neurological and psychological conditions. Research suggests it may interact with the endocannabinoid system, influencing mood and anxiety levels, making it a candidate for treating anxiety disorders and depression. Additionally, it has been explored for its neuroprotective properties, which could be beneficial in managing neurodegenerative diseases like Alzheimer's. Some studies also indicate its potential in reducing inflammation and pain, offering a natural alternative for pain management. Its role in promoting relaxation and improving sleep quality further highlights its versatility in addressing various health concerns. However, more clinical trials are needed to fully understand its efficacy and safety.